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Abstract
Spasticity is a poorly recognized but common symptom, present in a wide range
of neurological conditions. It can have a major impact on those affected, much of
which is potentially preventable. This chapter provides an excellent paradigm to
incorporate many of the key elements fundamental to the management of chronic
conditions and it is of relevance to those who work in spasticity rehabilitation.
Keywords: spasticity, rehabilitation, orthoses, drug, physiotherapy,
occupational therapy
1. Introduction
Spasticity is one of the common symptoms in a wide range of neurological
conditions, and it needs multidisciplinary approach for best management. This
chapter provides an excellent paradigm to incorporate many of the key elements
fundamental to the management of chronic conditions and it is of relevance to those
who work in spasticity rehabilitation. This chapter presents a comprehensive view
about rehabilitation with these subtitles:
• Assessment of the individual with spasticity
• Provision of education and promoting self-management
• Physical management of spasticity(physiotherapy or occupational therapy)
• Orthoses
• Pharmacological intervention
• Setting up a service
2. Assessment of the individual with spasticity
Accurate assessment of spasticity is the starting point to make a proper and
valuable plan for this route. In addition to assessing physical changes, resistance to
movement, weakness, and contractures, the impact of spasticity on the activities of
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daily life should be considered as well. These assessments should also be carried out
in the follow-up visits. In some references, it is recommended to perform the
assessments by a professional in this area in a multidisciplinary visit with a team of
specialists and clinicians instead of assessments by different specialists in several
visits. The assessment consists of two parts: history and physical examination.
2.1 History
The ultimate goal of assessment of history is to provide a thorough history that
encompasses the impact of the disease on the patient’s communications and inter-
actions with the environment and also covers all aspects of the disease. Therefore,
the provision of a checklist is recommended (Appendix 1). In addition to the
suggested questions, the answers to these two questions are very important in
history taking and should be included in the treatment plan: Does the spasticity
contribute to improving your performance? And is this spasticity a local problem or
a generalized one?
2.2 Physical examination
The physical examination involves three steps, as follows.
2.2.1 Observation
For observation, it is recommended to evaluate the items of posture, alignment,
presence of spontaneous spasms, seating if applicable, movement patterns when
moving (e.g., walking, transferring or picking up objects), and pressure sores.
However, observation alone is not enough and outcome measurements
(Appendix 2) such as timed 10-meter walk test and goniometry are useful.
2.2.2 Assessment of active movement, including range of motion and muscle strength
The grading scale of the Medical Research Council (MRC) (Table 1) can be used
to assess both weakness and spasticity. However, its application in severe to mod-
erate spasticity is difficult.
2.2.3 Assessment of resistance to passive movement, including assessment of the full range
of motion and contracture identification
Trunk and limb spasms are evaluated in this step. This assessment is usually
performed using the Modified Ashworth scale. However, it may fail to distinguish
Grade Definition
0 No contraction
1 Flicker of contraction only
2 Active movement with gravity eliminated
3 Active movement against gravity
4 Active movement against gravity and resistance
5 Normal power
Table 1.
Medical Research Council (MRC) grading of muscle strength.
2
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
between neuronal and non-neuronal causes of spasticity [1]; thus, the items
addressed in Table 2 should be noted to avoid misinterpretation [2]. It is effective
to use the Tardiu scale [3] to differentiate between the neuronal component and the
non-neuronal one because of the evaluation at different velocities [4]; however, it is
more time-consuming than the Ashworth test. It should be noted that the suggested
tests are specified for spasticity evaluation in limbs, and if one of the patient’s chief
complaints is trunk spasticity, the verbal or visual analog scales can be used as well
as measuring the distance between two fixed points on the trunk in fast and slow
trunk flexions by using a tape.
It is important to use outcome measures in clinical evaluation; however, it is
always challenging to maintain a balance between test simplicity and speed with its
reliability and validity [5], so different tests and methods have been suggested with
respect to the disease diagnosis. In this book, we recommend the outcome measure
of the National Hospital of Neurology and Neurosurgery (NHNN) in London with a
few modifications [2], which is typically used for patients with moderate to severe
spasticity (Appendix 2).
When the assessment is over and the treatment plan is being outlined, any physi-
cian should ask himself an important question: “why should I treat this spasticity?”
and the more important question is “what are the patient’s expectations of this
treatment?” So the ultimate goal should be discussed with the patients and their
caregivers to expect a realistic outcome. Since these goals are different for each
patient, the following desires can be addressed: sitting comfortably in a wheelchair,
adequate and comfortable night sleep, easier catheterization for bladder drainage, etc.
Different algorithms [6–8] have been developed for the evaluation of and ther-
apeutic approach to spasticity; one of the most applied of them has been developed
by Stevenson et al. [2] and is presented in Figure 1.
Perform three passive movements only and record the score of the resistance felt on the third
movement
The score is taken within the available range
Move the limbs in the best alignment possible, record position and use when repeating measures
Regulate the speed by counting 1001, 1002, 1003
Table 2.
Recommendations to standardize the measurement of the Ashworth scale.
Figure 1.
Therapeutic approach to spasticity.
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3. Provision of education and promoting self-management
Nowadays, it has been found that the patient’s awareness of the disease and the
situation he/she is dealing with promotes the therapeutic process and interventions.
This view and its results have also led to the development of courses known as
Expert Patient Programmes [9]. The patient and his/her caregivers’ understandings
of the medical conditions and therapeutic interventions are crucial and effective to
the treatment and therapeutic protocol selection. This is especially because different
therapeutic interventions for spasticity do not have a linear nature and several
treatments are sometimes considered for the patient at the same time (Figure 1).
To improve the spasticity treatment efficacy, some instructions should be
presented to the patient, either verbally or using a written material [10]. These
instructions include the following:
A.Maintaining movement and adequate positioning and B) Recognizing and
preventing factors that may aggravate or trigger spasticity and spasms.
B. Maintaining movement and adequate positioning:
A main factor in the spasticity treatment is to maintain the joints’ range of
motion, which should be performed by the patient or his/her caregiver.
Moreover, maintaining muscle length is the second factor that is usually
achieved by stretching or splinting [8]. Thus, sitting and standing positions are
also critical.
C. Recognizing and preventing factors that may exacerbate spasticity and spasms:
Elimination of unwanted sensory triggers is an important factor in spasticity
reduction. Naturally, cutaneous and visceral triggers (Table 3) regulate the
interneuronal activity by signaling to the spinal cord. Elimination and dysfunction
of some modulating pathways can inhibit polysynaptic reflexes (such as flexor
withdrawal) and cause spasm [11].
Similarly, abnormal activities of spinal cord circuits induce discharges in motor
neurons innervating several muscles, thereby causing a concurrent contraction of
these muscles and aggravating spasticity [12, 13]. Sometimes, some patients are
aware of such stimuli exacerbating their symptoms (e.g., bowel habit) while having
no clue how to modulate or reduce them. The patients should consider the
following:
1. Optimization of bladder and bowel management. Any defecation alteration
including urinary retention, infection, constipation, or diarrhea can
Cutaneous stimuli Visceral stimuli
Skin lesion (red or inflamed skin, broken skin,
infected skin, pressure sores, ingrown toenails)
Bowel and bladder dysfunction: for example,
constipation, overflow or diarrhea, infections,
retention or incomplete emptying
Tight-fitting clothes or urinary leg bag straps Any systemic or localized infection
Uncomfortable orthotics or seating systems Deep-vein thrombosis
Table 3.
Sensory stimulations that may aggravate spasticity.
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exacerbate the symptoms. Even the mild infection (e.g., Candida) can aggra-
vate the symptoms.
2. Maintaining skin integrity. Avoiding any skin irritation, infection, and pres-
sure sores is effective in spasticity reduction. So skin examinations, especially
in the vulnerable areas including the areas under pressure or under orthosis, as
well as preventing ingrown toenails and deep-vein thrombosis are needed.
Sometimes, there are individual factors that each patient gradually realizes (e.g.,
in some women, symptoms exacerbate during menstruation period). Knowledge of
some of these risk factors is important in treatment choice. In some cases,
elimination of some of these factors or waiting for a few days (e.g., in menstruation
period) and or a temporary rise in the drug dosage is very effective in solving the
patient’s problem.
Another point of patient education is that the weakness and spasticity are con-
comitant [2]; so the patient should know that sometimes the weakness becomes
more pronounced by medication use and subsequent spasticity reduction while
patients consider this effect as a drug side effect or lack of response. So, in case the
spasticity is an effective factor in preserving some of the patient’s functions (e.g.,
standing up and going to the bathroom in the morning), the medication should be
taken after the desired activity (going to the bathroom).
Patients should receive written information on the medication dosage, side
effects, and follow-up tests for the response to treatment. There should be a
telephone number in the form for convenient communication with the health care
center or the physician.
4. Physical management of spasticity(physiotherapy or occupational
therapy)
The key to a satisfying treatment for spasticity is to educate the patient properly
and ensure that the patient follows the instructions correctly. Also, as spasticity
changes during the treatment, treatment regimens should change with the patient’s
condition and be flexible. Proper patient management requires physiotherapy initi-
ation immediately after the disease diagnosis and at regular intervals throughout the
disease course, depending on the patient’s condition and the diagnosis made by the
treatment team. On the other hand, assessment and differentiation between the
neuronal and non-neuronal (connective tissue, joint component, muscle, and ten-
don) causes of hypertonia are critical because the treatment of non-neuronal [14]
(passive) causes involves physical therapies such as stretching and splinting; these
problems do not respond to medical treatments.
4.1 Physical management strategies
The goal of physical management is to maintain and even improve the perfor-
mance level and prevent the problems secondary to spasticity. In fact, spasticity
reduction is not always a treatment goal, as in some cases maintaining the patient’s
function requires a little spasticity and increased tone. Therefore, physical manage-
ment focuses on the performance, discomfort and pain relief, and prevention of
secondary complications including contractures and pressure ulcers. The key goals
of a physical management plan include the following [2]:
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• Maintaining the viscoelastic characteristics of tissues including tendons,
muscles, and joints to prevent contractures. This goal is achieved through
active and passive movements as well as standing and stretching with splints.
• Controlling the spasticity and spasm so that they will not be self-perpetuating;
for example, using techniques and methods in the situations and positions
exacerbating the symptoms.
• Maintaining the individual’s level of performance. It can be achieved by
strengthening activities and keeping cardiovascular fitness.
• Evaluation of spasticity as a positive factor in the patient’s function. But a
balance should be maintained between the benefits and spasticity-induced
complications.
• Generally, there is no single physical modality and the treatments are parallel
and concomitant, depending on the patient’s conditions. In the following, the
treatment options will be discussed in detail.
4.2 Standing
Standing is considered as a therapeutic option since it activates the anti-gravity
muscles, improves flexibility, reduces contractures, modulates the neuronal com-
ponent of spasticity, reduces sensory inputs and lower limb spasms, and has posi-
tive psychological effects [15–18]. Regarding the duration and frequency of this
physical therapy, studies have suggested a duration of between 30 minutes and
1.5 hours while most patients have performed this exercise for 40 minutes and with
a frequency of three to four times a week [18–20]. Remember that the duration and
frequency depend on the patient’s condition; so, the decision should be made based
on this factor. However, at least 30 minutes of standing seems to be reasonable. The
best standing position is in an extended posture with neutral alignment of the trunk,
pelvis, and lower limb joints, carried out actively by the patient himself/herself or
by using standing aids including Oswestry standing frames, motorized or hydrauli-
cally assisted standing systems, standing wheelchairs, or at least a tilt table
(according to the patient symptom severity respectively) [2]. In all these cases,
hypotension is the most notable complication, which can be prevented by arrange-
ments such as avoiding sudden position change or by using compression stockings.
4.3 Active exercise and promotion of optimal movement patterns
In most of the cases, patients with spasticity are advised for spasticity reduction
and less attention is paid to muscle weakness, and sometimes strengthening exer-
cises are not prescribed because of the concern for spasticity exacerbation [21]. It is
recommended, to the extent possible, to perform active exercises in order to
increase the strength, re-educate movement patterns, and improve cardiovascular
fitness. The outcomes achieved by these exercises are not usually observed in
passive exercises. Nowadays, it has been found that not only is antagonist muscle
weakness effective in spasticity, but also an imbalance between agonist and antag-
onist muscles exacerbates the symptoms and causes atrophy [21]. The movement
patterns should also change; in fact, proper movement patterns should be
instructed. At the same time with limb exercises, the alignments of the trunk and
pelvic girdle should be maintained. These exercises alter muscle functions and
structures [22]. The strengthening recommendations should be realistic and close to
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the patient’s daily life activities and include all the involved muscles [23, 24].
Although no specific protocol has been suggested for this kind of patients, most
studies recommend the protocol adapted from the sport sources. These traditional
training rates are a load of 60–80% of one repetition maximum (the maximum
load that can be lifted once), three sets of 10 repetitions carried out three or four
times a week.
Alongside these exercises, cardiovascular fitness exercises have been
recommended in various papers [25, 26]. Because these exercises are being
neglected in these patients due to their inactivity especially.
The task-focused active-use therapy techniques such as the constraint-induced
movement therapy can sometimes be used for upper limbs. The techniques should
be used in an intensive program over a short period (e.g., 4–8 weeks) [27].
4.4 Passive movement
When the patient cannot move his/her limb, passive movements can be carried
out by another person. In passive movement, generally, all the body joints should be
moved in their ranges of motion daily. According to the studies, it seems that using
passive movements can be effective in changing spasticity pattern, alleviating sec-
ondary non-neuronal complications, and improving positioning [2]. It is
recommended to perform the passive movements daily, and it can be carried out
before the patient repositioning. These movements should be safe and comfortable
for both the patient and caregiver. Spasmolytic medication taking in 20–30 minutes
before the movements can be helpful [2]. Sometimes sudden stretching can exacer-
bate the spasm, so the movements should be performed at slow speed. Skin irrita-
tions can cause symptom exacerbation as well; thus, the best way is to desensitize
the skin on a gradual basis or handling the limb on top of clothes. Grabbing and
holding the ball of the foot should be avoided because it is usually a sensitive point
for these triggers and better not to be touched [2]. Moreover, the movements
should be carried out with the best alignments of the muscles and joints,
overstretching should not occur, and stereotypical spasticity patterning (e.g.,
flexing the hip in the midline rather than in adduction and internal rotation) should
be avoided.
The critical point is that after the movements are over, the patient should be
positioned properly. The position should not be the same as the previous position
caused by spasms to keep the benefits of the movements [2]. Usually, these move-
ments are not performed by the physician or therapist because it is time-consuming
and is not cost-effective. So in addition to providing written material on the right
techniques for the patient and caregivers, assistance appliances such as continuous
passive movement machines (CPMs) or lifters (hoist) can also be used [2].
4.5 Stretches
Typically, with a 2-day immobilization, muscle changes initiate, including
muscle shortening and atrophy, muscle compliance reduction, and increasing the
ratio of collagen to muscle fibers [21]. Following these changes, there will be an
increase in the sensitivity of muscle spindles to stretching, which can exacerbate
the neuronal component of spasticity and subsequently the non-neural component
[28]. On the other hand, stretching induces actin and myosin synthesis; as a result,
the number of sarcomeres as well as the muscle length increases [21, 29]. So far,
there is no agreement on the duration and frequency of stretching exercises but the
following protocol can be considered for the daily schedule [30, 31].
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It is suggested to administer the stretching according to the patient’s daily
schedule and his/her posture [2]. The stretching can be carried out actively or
passively (by someone else or with FES). We can use the positioning, for example
standing, sitting, or lying down with using splints and orthosis, to achieve a
prolonged stretching. Another important point is that while stretching a muscle, the
antagonist muscle shortens, so there should be a balance in the stretching schedules
for all the muscles [2, 32]. Regarding the duration of stretching, studies have
suggested 20, 30, or even 60 minutes. So, there is no single protocol [30], but it
seems that the efficacy increases with longer durations. Also, it seems that
stretching before the exercises has a more favorable effect.
The patient should be given written instruction on stretching. Stretches should
include the back muscles, quadriceps, hip flexors, hip adductors, hamstrings, calf
muscles (gastrocnemius and soleus), wrists, and fingers, and should be performed
actively or passively. The therapist should modify the stretching based on each
patient’s condition.
4.6 Positioning
As well as improving the effective stretching and subsequent maintaining of
range of motion, correct positioning also helps in altering the spasticity pattern,
modifying asymmetry, and decreasing the risk of pressure-induced skin injuries
[33]. The golden key to good positioning is to change the position during the day.
An ideal position is important in both lying and sitting; moreover, the presence of
exacerbating factors and triggers (e.g., pressure sore, pain) is critical in position
selection. Performing passive exercises before positioning is helpful; for example,
when the patient tries to use a T roll for the leg flexion position, performing several
knee and hip flexions and bending the hips and knees up toward the chest and
abdomen facilitate this position [34].
In correct positioning, muscles should be stretched and longer than usual. For
example, these are the suggestions to improve the positioning in a patient with
continuous spasticity-induced hip adduction: The patient should monitor his/her
sitting position and try to keep his/her knees apart while sitting so that he/she does
not get accustomed to the wrong position. The impact of trunk and pelvis positions
on the legs should be evaluated. In a flexed posture with a posteriorly tilted pelvis,
the legs tend to be in internal rotation and adduction; so, having a firmer seat base, a
contoured cushion, or extra trunk support may facilitate a more anteriorly tilted
pelvis position, trunk extension, and better lower limbs alignment. In patients
unable to reduce adduction, using aids including a pummel, rolled-up towel,
cushion or T roll can help in reducing the adduction.
4.7 Wheelchair and seating
In patients suffering from spasticity, the sitting position should be modified to
improve the performance, accommodate to contractures and deformities
established, maintain comfort, and reduce fatigue [35, 36]. The main requirements
for a good sitting position are a firm seat base and backrest with subtle changes by
altering the seat base to promote an anterior tilt of the pelvis to help in achieving hip
flexion, abduction, and external rotation as well as trunk extension.
Patients with weakness in the trunk and neck extensors can use the tilt-in-space
systems [37, 38], where the patient seat has a reclining at the back and flexion at the
hip. In this system, hip flexion decreases the extension tone and spasticity as well as
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providing support for the patient’s back (by the backward movement of the back-
rest). Also, these seats improve kyphosis and breathing of the patients and reduce
fatigue and pressure ulcers.
As the patient’s spasticity status changes throughout the treatment, it is neces-
sary to re-evaluate the patient’s sitting position.
5. Orthosis
Orthoses or splints are tools for improving limb performance and preventing
deformity. These appliances are usually custom-made [39]. Non-removable
splinting devices made of plaster or casting tape are referred to as “casts.”
Casts are also a type of splint. Orthoses are used for the following treatment
goals [27, 39]:
• Providing control over the joint’s range of motion and thus improving its
performance.
• Maintaining prolonged stretches on the muscle’s tendon to alter or modify the
changes occurred in tissues.
• Modifying deformities established (e.g., using heel raise in leg length
discrepancy).
• Changing the neuronal component of spasticity through prolonged stretches
and sensory input alteration.
• Increasing the patient’s comfort.
• Correction of the posture.
• Correction of upper extremity performance.
• Improving walking efficiency.
• In children, preventing hip migration or slowing its progress.
In administering orthoses, in addition to discussing the treatment goals with
patients, the method of use, duration, and times of use should be discussed as well.
In each visit, the patient should be asked about pain, discomfort, and sleep disorder,
while muscle wasting and the places under pressure by orthosis should be exam-
ined. Incorrect orthosis usage and feeling discomfort with orthosis use can exacer-
bate the symptoms and cause new deformities. There is no contraindication for
administering orthoses; however, some problems addressed in Table 4 can limit the
use of splints, so these points should be noticed during the follow-up visits and
proper solutions should be considered [2].
The most common splints based on the usage area are discussed here according
to the evidence from different sources and guidelines. Evidence grading is
according to Tables 5 and 6 [40]. However, some of the splints are not mentioned
here, we did not intend to deny their effects but only the splints with the best
evidence are discussed.
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5.1 Ankle
The following advice is suggested to correct contractures [40]:
• It is possible to use casts at the end of the range of motion for acute brain injury
and stroke patients to improve the range of motion (2C). The cast should be
replaced every 5–7 days. Use the cast for a 2- to 12-week period.
• In severely spastic patients, we can use casts with botulinum toxin injection
(2B). The cast should be replaced every 5–7 days. Use the cast for a 2- to 12-
week period.
• Using adjustable ankle splints at the end of the range of motion improves
the joint’s range of motion (2C). Splints are used 6–23 hours a day for
Sensory impairment Uncontrolled epilepsy
Unstable intracranial pressure Heterotrophic ossification
Poor skin condition Edema
Vascular disorder Acute inflammation
Fracture or severe soft tissue injury Medically unstable
Behavioral/cognitive disorders Frequent spasms
Access to limb required for medical purposes
Table 4.
Precautions for the use of splints or orthoses.
Quality of
evidence
Grading Characteristics
High A Based on consistent results from well-performed randomized controlled
trials, or overwhelming evidence of an alternative source, for example, well-
executed observational studies with strong effects
Moderate B Based on randomized controlled trials where there are serious flaws in
conduct, inconsistency, indirectness, imprecise estimates, reporting bias, or
some other combination of these limitations, or from other study designs
with special strengths
Low C Based on observational evidence, or from controlled trials with several very
serious limitations
Very low D Based on case studies or expert opinion
Table 5.
GRADE quality of evidence grading.
Strength Grade Benefits and risks
Strong 1. “It is
recommended. ..”
Benefits appear to outweigh the risks (or vice versa) for the majority
of the target group
Conditional 2. “It is suggested.
..”
Risks and benefits are more closely balanced, or there is uncertainty
in likely service user values and preferences
Table 6.
Strength of grade.
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2–12 weeks and should be adjusted with improvements at the end of the range
of motion.
• While using non-custom-made splints, necessary precautions should be taken
to prevent pressure sores (2D).
Contracture prevention [40]:
• Using ankle casts at the end of dorsiflexion range can prevent contractures in
ABI patients (2C). Primary casts should be replaced every 5–7 days depending
on the change in the range of motion until the patient can maintain the plantar
grade position. The last cast should be used as a bivalved plantar grade cast for
18 hours a day until the splint can maintain the range of motion.
• The ankle splint can prevent the limitation of the ankle’s range of motion when
the ankle is at a plantar grade position (2B). The recommended duration of use
for ankle splint is 6–10 hours at night for 2–5 weeks.
• While using non-custom-made splints, necessary precautions should be taken
to prevent pressure sores (2B).
Performance improvement [41]:
• The plantar spasticity ankle foot orthosis (AFO) can be used for better walking.
In the case of mild spasticity, the single midline posterior stop AFO is used. The
type of AFO with pins in the posterior channels can be used for more severe
cases. Moreover, in patients with weak extensors of hip or knee, the solid type
is recommended while the hinged type is suitable for patients with adequate
control. In patients with crouched gait and passive range of motion in hip joints
and pelvis, a ground reaction force AFO can be used.
5.2 Knee
Contracture improvement [40]:
• It is possible to use casts at the end of range of motion for acute brain injury
and stroke patients to improve the knee’s range of motion (2D). The cast
should be replaced every 5–7 days. Use the cast for 2–12 weeks.
• Short-term application of the cast (1–4 days) entails fewer complications
compared to the longer uses (5–7 days) (2C).
Contracture prevention [40]:
• Using casts at the end of range of motion in acute brain injury and stroke
patients can prevent contractures (2C). The cast should be replaced every
5–7 days. Use the cast for a 2- to 5-week period.
• Use this cast with caution in the patients with acute lesions (acute brain injury
and stroke) and decreased level of consciousness for preventing secondary
complications such as pressure sores (2C).
• Knee splints can be used for standing control and walking improvement as well.
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5.3 Wrist and hand
Contracture improvement [2, 40]:
• Using splints for deformity correction in hand and wrists is not routinely
advised for every patient (e.g., in stroke and acute brain injury patients).
However, they can be used in certain cases in an optional way (2B). These
splints are custom-made or serial and adjustable (10 degrees wrist extension
and finger extension with MCP flexion, wrist at neutral, or maximal available
range of movement). Most of them are used for 20 minutes to 12 hours a day
for a 1- to 8-week period.
Contracture prevention [2, 40]:
• Using splints for deformity prevention in hand and wrists is not routinely
advised for every patient (e.g., in stroke and acute brain injury patients).
However, they can be used in certain cases in an optional way (2B). In the
studies, the splints have been used in different positions (10 degrees wrist
extension and fingers fully extended, wrist at neutral, or close to maximal
available range of movement) with duration of 6–12 hours a day for a 1- to 8-
week period.
• Using splints in combination with botulinum toxin in selected cases can be
effective in reducing the spasticity that has resulted in range of motion loss
(2C). The splint is used at the end of the available range of movement but is not
adjusted daily. On the other hand, strapping is used at the end of available
range of movement, with daily adjustment to maximal stretch for 6 days.
• Using electrical stimulation in combination with splints is not recommended
for contracture prevention (2A).
• Custom-made hand and wrist splints should not be used routinely for
prevention from spasticity exacerbation in acute brain injury and stroke
patients (2B).
• A wrist splint at neutral position can be effective in hand pain prevention
caused by joint malalignment (2A). These splints should be used for minimum
6 hours a day for 13 weeks.
Performance improvement [2, 42]:
• Sometimes, a splint is also used to improve performance (Figure 2) or prevent
tissue damage (e.g., sheepskin palm protector).
• Using volar splints in children with cerebral palsy can reduce the spasticity and
improve the range of motion and performance in upper limb. However, theses
splints are not effective on the upper limb movements in stroke patients.
• Using dorsal splints has no effect on spasticity, range of motion, and
performance of upper limb in stroke patients.
• Dynamic splints can improve the upper limb performance and accelerate
spasticity reduction.
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• The use of C-Bar splint is an effective method to improve hand performance
and range of motion while decreasing spasticity in upper limb of cerebral palsy
children.
• Using anti-pronation splints can be an effective technique to improve the
performance of upper limb, range of motion of forearm supination, and wrist
extension, as well as reducing the severity of spasticity in forearms pronator
muscles and wrist flexor muscles. These splints are also effective in improving
the gripping and pinching ability in children suffering from spastic diplegia
cerebral palsy.
• Extension splints are not helpful in the rehabilitation program of stroke
patients.
• As a modern splint, SAEBO splints can be helpful in improving the upper limb
of stroke patients.
• In general, volar, dorsal, anti-pronation, and C-Bar splints are effective in
spasticity reduction and performance improvement of upper limb in children
with cerebral palsy while SAEBO and dynamic splints are useful for
performance improvement and spasticity reduction of upper limb.
5.4 Elbow
Contracture improvement [40, 42]:
• Using casts is recommended at the end of range of motion to modify the
elbow’s range of motion (2C). The cast should be replaced every 3–7 days. Use
the cast for a 1- to 4-week period.
• Short-term application of the cast (1–4 days) entails fewer complications
compared to the longer use (4–7 days) (2C).
• Enough studies for contracture correction by splint are not available.
Figure 2.
sheepskin palm protector is used to prevent tissue damage.
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Contracture prevention [40]:
• Enough studies for contracture correction by splints are not available.
Performance improvement [42]:
• Elbow gaiters are recommended to maintain extension and improve function.
5.5 Spinal braces
• Spinal braces are usually used in cases with muscle weakness. In the patients
with spasticity being the predominant complaint, spinal braces are not
frequently used. It is because they are difficult to fit on the patients, are not
comfortable, and can induce breathing problems and sores [2]. In these cases,
the use of customized seating with individualized truncal and pelvic support
can be a more beneficial and comfortable option. The braces can be used in
patients with kyphosis and scoliosis if it helps in sitting.
6. Pharmacological intervention
On the decision for the treatment of spasticity, considering goals is a critical
point and pharmacological interventions should be considered with non-
pharmacological treatment for optimizing the effectiveness of management [2].
Another important point in prescription of drugs is about the patient’s situation and
the dosage and timing should be considered according to it. For example, painful
nocturnal spasms may best be managed with a long-acting agent taken at night-time
that has sedative side effects. As a rule for all medication, “start low and go slow”
[2]. Although it is time-consuming, this approach will limit any deleterious effects
on function or unwanted side effects. For better discussion, pharmacological inter-
ventions are categorized according to spasticity pattern including, generalized,
segmental, and focal.
6.1 Generalized spasticity
There are several oral treatments for management of generalized spasticity.
However, there is more interest for some medications according to the country
strategy (e.g., there is more discussion in American papers for Clonidine, but it is
currently little used in the UK) [39]. Generally, these drugs are used more for
spasticity management: baclofen, diazepam, tizanidine, dantrolene, gabapentin,
and clonidine (Table 7). They may be used to provide systemic effect for modest
spasticity severity. Choosing the drug is dependent on patient problems and goals
[2, 39]. For example, if the neuropathic pain is a problematic as well as spasticity,
gabapentin should be considered for this patient. Besides, some of the drugs are
more recommended in papers for specific diagnosis; for example, gabapentin is also
recommended as first- or second-line treatment for spasticity in the UK National
Guidelines for Multiple Sclerosis [39].
There is no evidence-based consensus for combination drug regimes for oral
treatment. However, they can be used according to associated features [2, 43].
There is no right or wrong way to titrate drugs in combination, and professionals
suggest avoiding polypharmacy. If there is intolerance for maximum dose of first-
line drug, continue the highest level the individual can tolerate comfortably and
added the second-line drug and titrated upward. If the patient’s problem has
14
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
been decreased with this regime, the first drug can be cautiously withdrawn to
see if monotherapy with the second-line drug alone is sufficient to achieve the
goal of treatment. For optimizing the treatment, it is very important the patient
has had written information about treatment goals and efficacy and side effects
of drugs.
Evidence-based recommendations for choosing the drug are listed below:
Baclofen: It is more effective in patients with either multiple sclerosis (MS) [44]
or spinal cord injury and few have concentrated on spasticity of cerebral origin,
including stroke or traumatic brain injury [43].
Tizanidine: It reduces sign and symptoms in MS, spinal cord injury and
stroke; no functional benefit has, however, been demonstrated in MS and spinal
cord injury [45].
Dantrolene: It is the only available agent that works out of CNS with direct
action on skeletal muscle. So, it can be prescribed for spasticity originating from
both spinal and supraspinal lesions. It is effective in management of MS patient
and has modest effect in spinal cord injury, stroke, and cerebral palsy [46–48]. It
does not demonstrate any changes in function.
Diazepam: The efficacy of it in spinal cord injury, cerebral palsy, and MS has
been proven. However, its side effects are more than those of other drugs in the
studies [43].
Gabapentin: There is beneficial effect of gabapentin on measures of spasticity in
MS and spinal cord injury [49, 50].
Clonidine: Its major use has been as an anti-hypertensive agent, but it is efficient
in the spinal cord injury spasticity [43].
In children’s spasticity, baclofen (for long treatment) and diazepam (for rapid
onset) are recommended by NICE guideline [27].
Drug Starting dose Maximum dose Side effects
Baclofen 5–10 mg daily 120 mg daily, usually in
three divided doses
Drowsiness, weakness, paresthesia,
nausea, vomiting
Diazepam 2 mg daily 40–60 mg daily, usually in
three or four divided doses
Drowsiness, reduced attention,
memory impairment
Dependency and withdrawal
syndromes
Tizanidine 2 mg daily 36 mg daily, usually in
three or four divided doses
Drowsiness, weakness, dry mouth,
postural hypotension
Monitor liver function
Dantrolene 25 mg daily 400 mg daily, usually in
four divided doses
Anorexia, nausea, vomiting,
drowsiness, weakness, dizziness,
paraesthesiae
Monitor liver function
Gabapentin 300 mg daily (can
start at 100 mg
daily)
2400 mg daily, usually in
three divided doses
Drowsiness, somnolence, dizziness
Table 7.
Drugs in spasticity treatment.
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6.2 For regional or segmental spasticity
This type of spasticity benefits from interathecal administration. This route of
administration delivers the medication directly to where it is needed with less
unwanted side effects like drowsiness and impaired cognition. Interathecal baclofen
pump has been used since 30 years ago [39]. It is effective for lower limbs and trunk
spasticity [51]. To manage changing needs, the dose and timing of drug delivery
can be programmed over the 24-hour period. It has the beneficial effect in the
autonomic storming in people with brain and spinal cord injury [39]. The risk of
infection and the need to attend clinics every 3 months or so to have the pump
refilled are its significant disadvantages.
The pump is recommended in children with severe motor function
impairment (GMFCS level 3, 4, and 5) and bilateral spasticity affecting upper and
lower limbs [27].
An intrathecal baclofen test to assess the therapeutic effect and adverse events is
necessary before making the decision for intrathecal pump implantation. For
evaluation of response, assessing the patient is necessary within 3–5 hours after
sedation and recovery. Before pump implantation, written information is necessary
including possible adverse effects, signs and symptoms suggesting the dose is too
low or high, complications and follow-up appointments [27].
Implantation of the infusion pump can occur within 3 months of satisfactory
response to intrathecal baclofen test [39].
Using intrathecal phenol injections is suggested in some studies too [52]. Com-
pared with the intrathecal phenol, baclofen pump has complication of surgical proce-
dure for implantation of pump, malfunction of pump, needing for dose adjustment
and refilling the pump [52]. The advantages of intrathecal phenol include: less indi-
vidual responsibility, low cost, no requirement of special equipment, and avoiding the
regular clinical visits for refills. But the complications of this procedure are bladder
and bowel incontinence, limb weakness, and paraesthesia, which are the reasons for
intrathecal phenol not being considered for spasticity management routinely [52].
6.3 Focal spasticity
The most famous treatments that are used in this category are phenol neurolysis
and botulinum toxin.
Phenol nerve block has been used for the treatment of spasticity since the 1960s
and it has advantages in comparison with botulinum toxin including: faster onset of
spasticity relief and greater degree of muscle relaxation for much longer and at
much less expense [27, 39]. But it has disadvantages including, neurogenic pain or
paraesthesia (if applied to a mixed motor/sensory nerve) and careful localization
(needing for experienced hand), so some specialist prefer Botulinum toxin. How-
ever, it is appropriate for patients with troublesome spasticity and dystonia of hip
adductors and calf muscles, especially for non-ambulant patients or “walkers” who
are already dependent on an ankle-foot orthosis (AFO) [27, 39].
Botulinum toxin use has shown significant effects on improving the symptoms
of patients with focal spasticity or dystonia [27, 39, 43]. The method of use and
injection is discussed in detail in chapter x. Here is a brief explanation of its indica-
tions and contraindications.
There is more interest in botulinum toxin injection. This procedure for patients
with focal spasticity in upper limb should be considered in the following cases [27]:
• Impeding fine motor function
• Compromising care and hygiene
16
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
• Causing pain
• Impeding tolerance of other treatments, such as orthoses
• Causing cosmetic concern to the child and young person
Botulinum toxin injection for patients with focal spasticity in lower limb should
be considered in the following cases [27]:
• Impeding gross motor function
• Compromising care and hygiene
• Causing pain
• Disturbing sleep
• Impeding tolerance of other treatments, such as orthoses and use of equipment
to support posture
• Causing cosmetic concern to the child and young person
Botulinum toxin is not recommended in the following cases [27]:
• Has severe muscle weakness
• Had previous adverse reaction or allergy to the botulinum toxin type A
• Is receiving aminoglycoside treatment
Administration of botulinum toxin should be done with caution in the following
cases [27]:
The person has any of the following:
• Bleeding disorders for example due to anticoagulant therapy
• Generalized spasticity
• Fixed muscle contracture
• Marked bone deformity
There are concerns about people likelihood of engaging in post treatment
adapted physical therapy treatment.
7. Setting up a service
Setting up a spasticity clinic or service depends on the local conditions and
available resources. Setting up a clinic needs a team in which every member has
certain tasks. Undoubtedly, the roles and duties will overlap, but it is important to
understand the abilities and skills of each professional to evaluate what they can
offer for the treatment process [2]. Thus, outlining the key skills and roles of each
team member and providing a competency framework can help in making an
efficient team.
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In general, four professionals have roles in a spasticity clinic team including a
physician (a pediatric or adult neurologist or a physical medicine and rehabilitation
specialist), nurse, occupational therapist, and physiotherapist [2]. In the following,
the tasks of each professional are briefly discussed.
Physician:
• Understanding the underlying condition, prognosis, natural history, associated
features, and possible complications. Identifying the abnormal features or
unexpected changes that may be caused by a secondary cause.
• Being experienced in neuromuscular history-taking and physical examination.
• Being able to perform necessary interventions including administering oral
medications, botulinum toxin injection, intrathecal drug, and splint.
Nurse:
• Educating the patient and his/her caregivers to manage spasticity.
• Managing cutaneous and visceral triggers.
• Advising the patient on posture, moving, and handling.
• Managing psychosocial issues and considering the impact of spasticity on
employment and social activities of the patient and managing it.
• Monitoring the patient’s and caregiver’s adaptations with the treatments and
ensuring that they follow the protocols and guidelines properly.
Physiotherapist:
• Identifying the potential for movement patterns and functional ability to be
improved.
• Identifying trigger factors of spasticity related to posture and movement.
• Identifying muscle weakness underlying the spasticity.
Occupational therapist:
• Assessing the patient for proper use of splints.
• Assessing the patient for posture and siting especially in a wheelchair.
• Assessing the impact of spasticity on the patient’s performance.
• Evaluating the patient’s access to work, home, and community environments.
Permanent presences of other specialists in the team are not necessarily needed,
but they can be helpful in the treatment process. These specialists include orthope-
dics, neurosurgeons, speech therapists, orthotists, social workers, continence advi-
sors, and psychologists.
One of the valuable points in setting up such services is their growth and
development to provide better services. This goal is achieved through data
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collection, organization, and extraction so that effective and useful proposals will be
presented. The development of these services based on this information results in
optimizing the services as much as possible and targeted funding for treating these
patients.
8. Conclusion
Spasticity is one of the common symptoms in a wide range of neurological
conditions and it needs a multidisciplinary approach for best management. This
chapter provided an excellent paradigm to incorporate many of the key elements
that are fundamental, including: assessment of the individual with spasticity, pro-
vision of education and promoting self-management, physical management of
spasticity (physiotherapy or occupational therapy), orthoses, pharmacological
intervention, and setting up a service.
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Appendix 1.
Demographic data and checklist for impact of the spasticity on the
patient’s communications and interactions with the environment.
Patient’s name: Date of birth: Date: Diagnosis:
Current medication Please comment on dose, route, times, and any side effects
experienced
Other medication used in the past for spasticity:
Why did they stop taking it (ineffective, not tolerated, other reason?)
Primary difficulty:
Is it attributed to spasticity: Yes/No
Severity rating out of 10
Other difficulties related to spasticity:
Spasticity Please comment on site and severity of spasticity
Not needing to be assessed
Clonus Please comment whether spontaneous
Not needing to be assessed
Spasms Please comment on which muscles, extensors or flexors, severity,
pain, frequency, and duration
Not needing to be assessed
Pain Please comment on presence, severity, and management.
Indicate if pain has been getting worse, better, or remains the
same
Not needing to be assessed
Sleep patterns Please comment on disturbances, positions, and quality
Bed mobility Please comment on how much, type of mattress used
Not needing to be assessed
Bladder Please comment on current management
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Patient’s name: Date of birth: Date: Diagnosis:
Not needing to be assessed
Bowel Please comment on current management
Not needing to be assessed
Skin Please comment on the presence of pressure ulcers and the ability
to relieve pressure, change position and sensation, and any aids
used (Waterlow Tool)
Not needing to be assessed
Mobility Please comment on outdoor, indoor, aids, speed, and distance
Not needing to be assessed
Toilet/bath/shower transfers Please comment on ability and aids required. Indicate if this has
been getting worse, better, or remains the same
Not needing to be assessed
Transfers Please comment on car, bed, chair, level of independence and
assistance required
Not needing to be assessed
Wheelchair Please comment on posture, position, type, and make of chair
and cushion
Not needing to be assessed
Previous therapy and nursing input Please comment on physiotherapy, OT, seating assessments, and
nursing advice. Ensure details of time, date, and location of
treatment obtained, including names, addresses, and contact
details
Options discussed with patient
Assessment by: Signature:
Appendix 2. The outcome measures of spasticity
Name: Data
Goniometry to measure range of passive movement
(Norkin and White 1985):
Resting angle
Right/left
Full range
available Right/
left
Hip flexion-extension
Hip abduction-adduction
Knee flexion-extension
Ankle PF-DF
Maximum distance between knees as measured during
passive hip abduction (Hyman 2000):
Distance in mm:
Modified Ashworth scale (Bohannon and Smith,1987): Right Left
Resistance to: hip and knee flexion in supine
Resistance to: hip and knee extension
in supine
Resistance to: hip abduction in crook lying
Resistance to: ankle dorsiflexion with knee
extended
Clonus and spasms score (self-report) (Smith 1994)*
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Name: Data
Clonus
Spasms
Pain intensity by visual analogue scale(VAS)
Seating posture score (please record 0 = yes, 1 = no)
Are the feet well positioned on the footplates?
Are the knees apart?
Are the hips well aligned?
Is the trunk posture symmetrical?
Total
Record the frequency of falls over the last month(0 = No
falls, 1 = two to three falls per week,
2 = five to six falls per week, 3 = daily falls,
4 = more than one fall per day)
10-metre timed walk (Wade 1987)
No. of steps
Time
Aid used
Identify the main problem that is amenable to treatment:
*0 = absent; 1 = Provoked by painful stimuli only; 2 = Provoked by touch, light pressure and/or occasionally
spontaneous (5/day and/or < 2night); 3 = Provoked by passive movements (during physical therapy or nursing care)
and/or frequently spontaneous (>5 day and/or 2/night).
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